Latest 10-K annual reports

Glen Burnie Bancorp experienced a net loss of $0.1 million in 2024, a significant downturn compared to the $1.4 million net income in 2023, primarily due to decreased net interest income and increased expenses.

Hepion Pharmaceuticals reports its 2024 financial results, highlighting a strategic restructuring, termination of a merger agreement, and substantial doubt about its ability to continue as a going concern.

Jingbo Technology files an amended 10-K, restating prior financials and highlighting concerns about its ability to continue as a going concern.

Gold Resource Corporation's 2024 10-K filing reveals substantial doubt about the company's ability to continue as a going concern due to production declines, equipment issues, and insufficient liquidity.

Capstone Companies, Inc. files an amendment to its 2024 annual report to correct minor typographical errors and update exhibit information.

BioLife Solutions has filed an amendment to its 2024 Annual Report to restate Part III, covering directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, director independence, and principal accounting fees, and to file new certifications.

Mama's Creations, Inc. reports a 19% increase in net sales for the year ended January 31, 2025, but acknowledges challenges related to manufacturing inefficiencies and rising commodity costs.

BioForce Nanosciences Holdings reports no revenue for FY 2024, a net loss of $490,437, and expresses substantial doubt about its ability to continue as a going concern.

Ocean Biomedical, Inc. files its annual report on Form 10-K, detailing its financial results for the year ended December 31, 2024, and providing an update on its preclinical development programs.

Ameritek Ventures, Inc. reports a significant increase in net income for 2024, driven by a gain on asset disposal from the sale of Ecker Capital to ZenaTech, despite a decrease in operating revenue.

The Dixie Group's 2024 10-K filing reveals delisting from Nasdaq, increased net losses, and concerns about meeting financial covenants despite a new credit facility.

Marblegate Capital Corporation's 10-K filing highlights its focus on NYC taxi medallion lending, fleet operations, and strategic initiatives amidst industry challenges and regulatory changes.

NovelStem International Corp.'s 2024 10-K filing reveals substantial net losses, an impairment of its NewStem investment, and ongoing concerns about its ability to continue as a going concern.

Altair International Corp.'s 10-K filing details the acquisition of Premier Air Charter, financial results, risk factors, and future strategies for the fiscal year ended December 31, 2024.

CXApp Inc.'s latest 10-K filing outlines the company's stock structure, warrant details, and corporate governance policies as of March 31, 2025.

Mobiquity Technologies, Inc. files its 10-K report for fiscal year 2024, detailing financial performance and strategic initiatives, including an expanded partnership with Context Networks.

The Bancorp restates its financial statements for fiscal years 2022-2024 due to an incomplete closing procedure and auditor non-approval, revealing material weaknesses in internal controls.

Titan Machinery Inc. reports a decrease in revenue and profitability for fiscal year 2025, impacted by challenging industry conditions and macroeconomic factors.

Artisan Consumer Goods files an amended 10-K to reflect a re-audit by a new accounting firm following the revocation of its previous auditor's registration, while also expressing substantial doubt about its ability to continue as a going concern.

MetroCity Bankshares, Inc. files an amendment to its 2024 Annual Report on Form 10-K to correct a misidentification in the Independent Registered Public Accounting Firm's consent and to include reference to the effectiveness of internal control over financial reporting.

Totaligent, Inc. reports a net loss for 2024 as it focuses on launching its integrated digital marketing platform, shifting from managed campaigns to a consumer-facing model.

Dave & Buster's Entertainment, Inc. reports a decrease in fiscal 2024 revenue and comparable store sales, alongside a drop in net income, as it navigates a changing consumer landscape and invests in strategic initiatives.

Merus N.V. files an amendment to its annual report on Form 10-K to include its Insider Trading Compliance Policy, which was inadvertently omitted from the original filing.

Rein Therapeutics reports its 10-K filing, highlighting positive clinical data for LTI-03 but also raising concerns about its ability to continue as a going concern due to insufficient funds.

Quetta Acquisition Corporation's 10-K filing details its financial status, the proposed merger with KM QUAD, and efforts to extend its business combination deadline.

AgriFORCE Growing Systems outlines its business ethics policy and provides a financial update in its annual 10-K filing, highlighting its shift towards sustainable technology and Bitcoin mining.

Mobivity Holdings Corp.'s 2024 10-K filing reveals a slight revenue increase alongside significant net losses and ongoing concerns about the company's ability to continue as a going concern.

Aspire Biopharma Holdings finalizes its business combination and is gearing up for clinical trials and FDA Fast Track designation for its high-dose sublingual aspirin product.

DynaResource, Inc. reports a 31% increase in revenue for 2024, driven by higher gold prices and increased production at its San Jose de Gracia mine, with plans for further throughput expansion and exploration in 2025.

ENDRA Life Sciences files an amendment to its annual report to correct a typographical error in the auditor's report regarding the date and PCAOB ID number.